ea0063p36 | Adrenal and Neuroendocrine Tumours 1 | ECE2019
Altieri Barbara
, Barrea Luigi
, Modica Roberta
, Circelli Luisa
, Bottiglieri Filomena
, Cicco Federica De
, Savarese Giovanni
, Somma Carolina Di
, Colao Annamaria
, Savastano Silvia
, Faggiano Antongiulio
Background: Vitamin D has several ‘noncalcemic’ implications, including effects on cell signaling and differentiation. Patients with gastroenteropancreatic (GEP) neuroendocrine tumors (NET) have an increased risk of vitamin D deficiency, due to the tumor itself, systemic therapies and abdominal surgery. However, data regarding vitamin D status are limited. Aim of this study was to evaluate 25-hydroxy-vitamin-D (25(OH)D) levels in GEP-NET patients and correlated them ...